Dr Xu has a strong belief in the importance of a kind and compassionate approach to care. He has rich experience in radiation oncology in most common cancers, and is able to make reasonable and optimal treatment plans for patients.
Dr Xiangsheng Xu graduated from The Force Military Medical University in 1999 and acquired a Master’s Degree in Immunology in 2006, and Doctor’s Degree in Pathology and Pathophysiology in 2009.
He then worked as a radiation oncologist at Air Force General Hospital in Beijing, specialising in radiation therapy for lung cancer, esophagus cancer, head and neck cancer, and abdominal and pelvic carcinoma.
Affiliations & Memberships
- Member of esophageal cancer group of Cancer Radiotherapy Committee of Beijing Medical Association
- Member of Beijing Academy of Precision Radiotherapy
- Breast cancer
- Cervical cancer
- Hepatocellular carcinoma
- Lung cancer
- Oesophagus cancer
- Prostate cancer
- Rectal cancer
BTLA down-regulation by HIV-1 depends on type I interferon and contributes to T cell hyper-activation. J Infect Dis, 2011,203: 1668-1678
Reversal of B-cell hyperactivation induced by follicular helper T cells is associated with HBsAg seroconversion in chronic hepatitis B patients. Cell Mol Immunol. 2015,12(3):309-316
BTLA Characterization and its association with disease progression in patients with chronic HIV-1 infection. Chinese Journal of Cellular and Molecular Immunology, 2009, 25(12):1158-1160
Two extracellular Ig-like domains of mouse PTA1 (CD226) involved in the interaction with its ligand mouse Tage4 (CD155). Journal of The Fourth Military Medical University, 2006, 27(15):1353-1356
Murine PTA1/CD226 is involved in the differentiation of cytotoxic T lymphocytes. Chinese Journal of Microbiology and Immunology, 2006, 26(1):32-35